翻訳と辞書 |
JNJ-26990990 : ウィキペディア英語版 | JNJ-26990990
JNJ-26990990 is a broad-spectrum anticonvulsant drug currently under development by Janssen Pharmaceutica as a second-generation followup to the marketed drug topiramate. It was designed to have the same anticonvulsant effects as topirimate, but without the side effects associated with topiramate's carbonic anhydrase inhibition.〔 It also has potential use in the treatment of inflammatory pain, neuropathic pain, and depression.〔(【引用サイトリンク】 publisher = R & D Focus Drug News )〕 JNJ-26990990 entered phase II clinical trials in October 2007. Metabolites and radioactive isotope-labeled derivatives of JNJ-26990990 have also been prepared to support its development. ==See also==
* JNJ-26489112
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「JNJ-26990990」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|